H.R. 931 - HEAL Act
- Sponsor:
- Rosa L. DeLauro
- Summary:
- To provide for approval of certain drugs and biological products indicated for use in a well-defined population of patients in order to address increases in bacterial resistance to drugs and biological products, and for other purposes. (by CRS)
- Status:
- The bill has been referred to committee.
HEAL Act
H.R. 931 — 114th Congress (2015–2016)
- Summary
- To provide for approval of certain drugs and biological products indicated for use in a well-defined population of patients in order to address increases in bacterial resistance to drugs and biological products, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To provide for approval of certain drugs and biological products indicated for use in a well-defined population of patients in order to address increases in bacterial resistance to drugs and biological products, and for other purposes.
- Other Titles
- HEAL Act
- Helping Effective Antibiotics Last Act of 2015
- HEAL Act
- Sponsor
- Rosa L. DeLauro
- Co-Sponsors
- Subjects
- Health
- Administrative law and regulatory procedures
- Administrative remedies
- Consumer affairs
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Food and Drug Administration (FDA)
- Government information and archives
- Health information and medical records
- Infectious and parasitic diseases
- Licensing and registrations
- Medical research
- Prescription drugs
- Related Bills
- Major Actions
Introduced 2/12/2015 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 2/12/2015 2/12/2015 Referred to the House Committee on Energy and Commerce. 2/12/2015 Introduced in House 2/13/2015 Referred to the Subcommittee on Health. Number Sponsor Date Offered Status
Total contributions given to House members from interest groups that…
Contributions data source: OpenSecrets.org